Work

Real-world brain metastasis outcomes with T-DXd versus tucatinib-based therapy in second-line HER2-positive metastatic breast cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.1051

Authors: Zunairah Shah, Han Yu, Safa Saadat Afridi, Song Yao, Shipra Gandhi, Sheheryar Kairas Kabraji

Institutions: Roswell Park Comprehensive Cancer Center, SUNY Upstate Medical University, Winship Cancer Institute

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162560008

Cites:

Cited by:

Related to: